{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:34:18Z","timestamp":1791945258581,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12728-7","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:21:04Z","timestamp":1754994064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides"],"prefix":"10.1038","volume":"15","author":[{"given":"Yasir","family":"Mehmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Momena","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad N.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bourhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhreldeen","family":"Dabiellil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"AL Mughram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"12728_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejps.2016.06.018","volume":"92","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. Liraglutide-loaded Poly (lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation. Eur. J. Pharm. Sci. 92, 28\u201338 (2016).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20133","key":"12728_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/20468954.2024.2366693","volume":"13","author":"A Pandey","year":"2024","unstructured":"Pandey, A. & Goyal, A. K. Liraglutide innovations: a comprehensive review of patents (2014\u20132024). Pharm. Patent Analyst. 13 (1\u20133), 73\u201389 (2024).","journal-title":"Pharm. Patent Analyst"},{"issue":"17","key":"12728_CR3","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2165\/11208110-000000000-00000","volume":"71","author":"CM Perry","year":"2011","unstructured":"Perry, C. M. Liraglutide Drugs, 71(17): 2347\u20132373. (2011).","journal-title":"Liraglutide Drugs"},{"issue":"8","key":"12728_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/BF03345744","volume":"32","author":"G Aimaretti","year":"2009","unstructured":"Aimaretti, G. Liraglutide: a once-daily human glucagon-like peptide-1 analogue. J. Endocrinol. Investig. 32 (8), 701\u2013703 (2009).","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"12728_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejps.2008.12.017","volume":"37","author":"A Graf","year":"2009","unstructured":"Graf, A., Rades, T. & Hook, S. M. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation. Eur. J. Pharm. Sci. 37 (1), 53\u201361 (2009).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"12728_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00396-014-3394-6","volume":"293","author":"G Jiang","year":"2015","unstructured":"Jiang, G. et al. Preparation of multi-responsive micelles for controlled release of insulin. Colloid Polym. Sci. 293 (1), 209\u2013215 (2015).","journal-title":"Colloid Polym. Sci."},{"issue":"1","key":"12728_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C Leuner","year":"2000","unstructured":"Leuner, C. & Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (1), 47\u201360 (2000).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"12728_CR8","doi-asserted-by":"publisher","first-page":"p2129","DOI":"10.2147\/DDDT.S166989","volume":"12","author":"A Bai","year":"2018","unstructured":"Bai, A. et al. Development of a Tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of Fenofibrate. Drug. Des. Devel. Ther. 12, p2129 (2018).","journal-title":"Drug. Des. Devel. Ther."},{"issue":"2","key":"12728_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2008.03.002","volume":"128","author":"H De Waard","year":"2008","unstructured":"De Waard, H., Hinrichs, W. & Frijlink, H. A novel bottom\u2013up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J. Controlled Release. 128 (2), 179\u2013183 (2008).","journal-title":"J. Controlled Release"},{"issue":"1","key":"12728_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijpharm.2011.01.059","volume":"408","author":"W Li","year":"2011","unstructured":"Li, W. et al. Preparation and in vitro\/in vivo evaluation of Revaprazan hydrochloride nanosuspension. Int. J. Pharm. 408 (1), 157\u2013162 (2011).","journal-title":"Int. J. Pharm."},{"issue":"15","key":"12728_CR11","doi-asserted-by":"publisher","first-page":"155104","DOI":"10.1088\/0957-4484\/21\/15\/155104","volume":"21","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. In vitro and in vivo evaluation of Silybin nanosuspensions for oral and intravenous delivery. Nanotechnology 21 (15), 155104 (2010).","journal-title":"Nanotechnology"},{"issue":"7","key":"12728_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/10611860903548362","volume":"18","author":"V Bali","year":"2010","unstructured":"Bali, V., Ali, M. & Ali, J. Novel nanoemulsion for minimizing variations in bioavailability of Ezetimibe. J. Drug Target. 18 (7), 506\u2013519 (2010).","journal-title":"J. Drug Target."},{"issue":"1","key":"12728_CR13","first-page":"32","volume":"64","author":"A Silva","year":"2009","unstructured":"Silva, A. et al. Development of topical nanoemulsions containing the isoflavone genistein. Die Pharmazie-An Int. J. Pharm. Sci. 64 (1), 32\u201335 (2009).","journal-title":"Die Pharmazie-An Int. J. Pharm. Sci."},{"issue":"2","key":"12728_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1021\/mp700091j","volume":"5","author":"JB Tagne","year":"2008","unstructured":"Tagne, J. B. et al. A nanoemulsion formulation of Tamoxifen increases its efficacy in a breast cancer cell line. Mol. Pharm. 5 (2), 280\u2013286 (2008).","journal-title":"Mol. Pharm."},{"issue":"4","key":"12728_CR15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-08-3231","volume":"69","author":"C Khemtong","year":"2009","unstructured":"Khemtong, C. et al. In vivo off-resonance saturation magnetic resonance imaging of \u03b1v\u03b23-targeted superparamagnetic nanoparticles. Cancer Res. 69 (4), 1651\u20131658 (2009).","journal-title":"Cancer Res."},{"issue":"28","key":"12728_CR16","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1016\/j.biomaterials.2010.06.004","volume":"31","author":"TH Kim","year":"2010","unstructured":"Kim, T. H. et al. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31 (28), 7386\u20137397 (2010).","journal-title":"Biomaterials"},{"key":"12728_CR17","doi-asserted-by":"crossref","unstructured":"Hughes, G. A. Nanostructure-mediated drug delivery, in Nanomedicine in Cancer. Pan Stanford. pp. 47\u201372. (2017).","DOI":"10.1201\/b22358-2"},{"issue":"4","key":"12728_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"M Hans","year":"2002","unstructured":"Hans, M. & Lowman, A. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 6 (4), 319\u2013327 (2002).","journal-title":"Curr. Opin. Solid State Mater. Sci."},{"issue":"3","key":"12728_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/2230-973X.160844","volume":"5","author":"C Bharti","year":"2015","unstructured":"Bharti, C. et al. Mesoporous silica nanoparticles in target drug delivery system: A review. Int. J. Pharm. Invest. 5 (3), 124 (2015).","journal-title":"Int. J. Pharm. Invest."},{"issue":"13","key":"12728_CR20","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1039\/C5NR09112H","volume":"8","author":"L Maggini","year":"2016","unstructured":"Maggini, L. et al. Breakable mesoporous silica nanoparticles for targeted drug delivery. Nanoscale 8 (13), 7240\u20137247 (2016).","journal-title":"Nanoscale"},{"issue":"3","key":"12728_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.taap.2006.10.004","volume":"217","author":"W Lin","year":"2006","unstructured":"Lin, W. et al. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmcol. 217 (3), 252\u2013259 (2006).","journal-title":"Toxicol. Appl. Pharmcol."},{"issue":"9","key":"12728_CR22","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1007\/s00210-024-03082-y","volume":"397","author":"S Bourang","year":"2024","unstructured":"Bourang, S. et al. Application of nanoparticles in breast cancer treatment: a systematic review. Naunyn. Schmiedebergs Arch. Pharmacol. 397 (9), 6459\u20136505 (2024).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"12728_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jconrel.2018.08.032","volume":"287","author":"P Tyagi","year":"2018","unstructured":"Tyagi, P., Pechenov, S. & Subramony, J. A. Oral peptide delivery: translational challenges due to physiological effects. J. Controlled Release. 287, 167\u2013176 (2018).","journal-title":"J. Controlled Release"},{"key":"12728_CR24","doi-asserted-by":"publisher","first-page":"100821","DOI":"10.1016\/j.mser.2024.100821","volume":"160","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Huang, C. & Xiong, R. Advanced materials for intracellular delivery of plant cells: strategies, mechanisms and applications. Mater. Sci. Engineering: R: Rep. 160, 100821 (2024).","journal-title":"Mater. Sci. Engineering: R: Rep."},{"issue":"2","key":"12728_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1039\/C2BM00085G","volume":"1","author":"M Colilla","year":"2013","unstructured":"Colilla, M., Gonz\u00e1lez, B. & Vallet-Reg\u00ed, M. Mesoporous silica nanoparticles for the design of smart delivery nanodevices. Biomaterials Sci. 1 (2), 114\u2013134 (2013).","journal-title":"Biomaterials Sci."},{"issue":"1","key":"12728_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1021\/cr00099a003","volume":"90","author":"LL Hench","year":"1990","unstructured":"Hench, L. L. & West, J. K. The sol-gel process. Chem. Rev. 90 (1), 33\u201372 (1990).","journal-title":"Chem. Rev."},{"issue":"4","key":"12728_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1208\/s12249-014-0273-x","volume":"16","author":"M Ganesh","year":"2015","unstructured":"Ganesh, M. et al. Development of Duloxetine hydrochloride loaded mesoporous silica nanoparticles: characterizations and in vitro evaluation. AAPS PharmSciTech. 16 (4), 944\u2013951 (2015).","journal-title":"AAPS PharmSciTech"},{"issue":"47","key":"12728_CR28","doi-asserted-by":"publisher","first-page":"32211","DOI":"10.1021\/acsami.6b11324","volume":"8","author":"J Tu","year":"2016","unstructured":"Tu, J. et al. Mesoporous silica nanoparticles with large pores for the encapsulation and release of proteins. ACS Appl. Mater. Interfaces. 8 (47), 32211\u201332219 (2016).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"26","key":"12728_CR29","doi-asserted-by":"publisher","first-page":"23812","DOI":"10.1021\/acsomega.3c02186","volume":"8","author":"Y Mehmood","year":"2023","unstructured":"Mehmood, Y. et al. Developing nanosuspension loaded with azelastine for potential nasal drug delivery: determination of Proinflammatory Interleukin IL-4 MRNA expression and industrial Scale-Up strategy. ACS Omega. 8 (26), 23812\u201323824 (2023).","journal-title":"ACS Omega"},{"issue":"3","key":"12728_CR30","first-page":"915","volume":"36","author":"Y Mehmood","year":"2023","unstructured":"Mehmood, Y. et al. Control synthesis of mesoporous silica microparticles: optimization and in vitro cytotoxicity studies. Pak. J. Pharm. Sci. 36 (3), 915\u2013920 (2023).","journal-title":"Pak. J. Pharm. Sci."},{"issue":"7","key":"12728_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11051-023-05784-5","volume":"25","author":"Y Mehmood","year":"2023","unstructured":"Mehmood, Y. et al. Remdesivir nanosuspension for potential nasal drug delivery: determination of pro-inflammatory Interleukin IL-4 mRNA expression and industrial scale-up strategy. J. Nanopart. Res. 25 (7), 129 (2023).","journal-title":"J. Nanopart. Res."},{"key":"12728_CR32","unstructured":"Mehmood, Y. et al. Biopolymer based film loaded with cholecalciferol: A novel technique to enhance nutritional supplement absorbance. Pak. J. Pharm. Sci., 36. (2023)."},{"issue":"20","key":"12728_CR33","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/adfm.200800521","volume":"18","author":"CH Lee","year":"2008","unstructured":"Lee, C. H. et al. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti\u2010inflammatory drug. Adv. Funct. Mater. 18 (20), 3283\u20133292 (2008).","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"12728_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/gels9070551","volume":"9","author":"Y Mehmood","year":"2023","unstructured":"Mehmood, Y. et al. Amikacin-loaded Chitosan hydrogel film cross-linked with folic acid for wound healing application. Gels 9 (7), 551 (2023).","journal-title":"Gels"},{"issue":"2","key":"12728_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/03639045.2015.1039018","volume":"42","author":"Z Zhao","year":"2016","unstructured":"Zhao, Z. et al. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release Fenofibrate tablets. Drug Dev. Ind. Pharm. 42 (2), 199\u2013208 (2016).","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20132","key":"12728_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000337597","volume":"29","author":"A Nemmar","year":"2012","unstructured":"Nemmar, A. et al. Interaction of diesel exhaust particles with human, rat and mouse erythrocytes in vitro. Cell. Physiol. Biochem. 29 (1\u20132), 163\u2013170 (2012).","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"12728_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1289\/ehp.11811","volume":"117","author":"S Lu","year":"2008","unstructured":"Lu, S. et al. Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ. Health Perspect. 117 (2), 241\u2013247 (2008).","journal-title":"Environ. Health Perspect."},{"key":"12728_CR38","doi-asserted-by":"publisher","first-page":"S1460","DOI":"10.1016\/j.arabjc.2013.04.024","volume":"10","author":"M Zubair","year":"2017","unstructured":"Zubair, M. et al. GC\/MS profiling, in vitro antioxidant, antimicrobial and haemolytic activities of Smilax macrophylla leaves. Arab. J. Chem. 10, S1460\u2013S1468 (2017).","journal-title":"Arab. J. Chem."},{"issue":"3","key":"12728_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12 (3), 263\u2013271 (2010).","journal-title":"AAPS J."},{"issue":"6","key":"12728_CR40","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/adv.21840","volume":"37","author":"K Barkat","year":"2018","unstructured":"Barkat, K. et al. Development and characterization of pH-responsive polyethylene glycol\u2010co\u2010poly (methacrylic acid) polymeric network system for colon target delivery of oxaliplatin: its acute oral toxicity study. Adv. Polym. Technol. 37 (6), 1806\u20131822 (2018).","journal-title":"Adv. Polym. Technol."},{"issue":"3","key":"12728_CR41","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00289-017-2079-y","volume":"75","author":"I Khalid","year":"2018","unstructured":"Khalid, I. et al. Preparation and characterization of alginate-PVA-based semi-IPN: controlled release pH-responsive composites. Polym. Bull. 75 (3), 1075\u20131099 (2018).","journal-title":"Polym. Bull."},{"issue":"38","key":"12728_CR42","doi-asserted-by":"publisher","first-page":"45312","DOI":"10.1002\/app.45312","volume":"134","author":"K Barkat","year":"2017","unstructured":"Barkat, K. et al. Oxaliplatin-loaded crosslinked polymeric network of chondroitin sulfate\u2010co\u2010poly (methacrylic acid) for colorectal cancer: its toxicological evaluation. J. Appl. Polym. Sci. 134 (38), 45312 (2017).","journal-title":"J. Appl. Polym. Sci."},{"issue":"27","key":"12728_CR43","doi-asserted-by":"publisher","first-page":"13158","DOI":"10.1021\/jp201017e","volume":"115","author":"YD Chiang","year":"2011","unstructured":"Chiang, Y. D. et al. Controlling particle size and structural properties of mesoporous silica nanoparticles using the Taguchi method. J. Phys. Chem. C. 115 (27), 13158\u201313165 (2011).","journal-title":"J. Phys. Chem. C"},{"key":"12728_CR44","doi-asserted-by":"crossref","unstructured":"Morsi, R. E. & Mohamed, R. S. Nanostructured Mesoporous Silica: Influence of the Preparation Conditions on the physical-surface Properties for Efficient Organic Dye Uptake5p. 172021 (Royal Society open science, 2018). 3.","DOI":"10.1098\/rsos.172021"},{"issue":"2","key":"12728_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/toxsci\/kfj099","volume":"90","author":"KW Powers","year":"2006","unstructured":"Powers, K. W. et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90 (2), 296\u2013303 (2006).","journal-title":"Toxicol. Sci."},{"key":"12728_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/NSA.S91785","volume":"8","author":"MJ Masarudin","year":"2015","unstructured":"Masarudin, M. J. et al. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse Chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14\u00a0C]-doxorubicin. Nanatechnol. Sci. Appl. 8, 67 (2015).","journal-title":"Nanatechnol. Sci. Appl."},{"key":"12728_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.micromeso.2012.02.037","volume":"158","author":"F Sevimli","year":"2012","unstructured":"Sevimli, F. & Y\u0131lmaz, A. Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater. 158, 281\u2013291 (2012).","journal-title":"Microporous Mesoporous Mater."},{"issue":"10","key":"12728_CR48","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1039\/C4TB02073A","volume":"3","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. Outside-in Stepwise functionalization of mesoporous silica nanocarriers for matrix type sustained release of fluoroquinolone drugs. J. Mater. Chem. B. 3 (10), 2206\u20132214 (2015).","journal-title":"J. Mater. Chem. B"},{"key":"12728_CR49","first-page":"287","volume":"10","author":"A Beganskien\u0117","year":"2004","unstructured":"Beganskien\u0117, A. et al. FTIR, TEM and NMR investigations of St\u00f6ber silica nanoparticles. Mater. Sci. (Med\u017eiagotyra). 10, 287\u2013290 (2004).","journal-title":"Mater. Sci. (Med\u017eiagotyra)"},{"issue":"3","key":"12728_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/pharmaceutics10030118","volume":"10","author":"R Narayan","year":"2018","unstructured":"Narayan, R. et al. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics 10 (3), 118 (2018).","journal-title":"Pharmaceutics"},{"issue":"3","key":"12728_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2010.04.029","volume":"145","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug Telmisartan. J. Controlled Release. 145 (3), 257\u2013263 (2010).","journal-title":"J. Controlled Release"},{"issue":"2\u20133","key":"12728_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","volume":"108","author":"J Salonen","year":"2005","unstructured":"Salonen, J. et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Controlled Release. 108 (2\u20133), 362\u2013374 (2005).","journal-title":"J. Controlled Release"},{"issue":"1","key":"12728_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2006.09.019","volume":"331","author":"T Heikkil\u00e4","year":"2007","unstructured":"Heikkil\u00e4, T. et al. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharm. 331 (1), 133\u2013138 (2007).","journal-title":"Int. J. Pharm."},{"issue":"20","key":"12728_CR54","doi-asserted-by":"publisher","first-page":"9899","DOI":"10.1039\/D3NR05655D","volume":"16","author":"HM Johnsen","year":"2024","unstructured":"Johnsen, H. M. et al. Stable snow lantern-like aggregates of silicon nanoparticles suitable as a drug delivery platform. Nanoscale 16 (20), 9899\u20139910 (2024).","journal-title":"Nanoscale"},{"issue":"2","key":"12728_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/17425247.2015.1111335","volume":"13","author":"A Maleki","year":"2016","unstructured":"Maleki, A. & Hamidi, M. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. Expert Opin. Drug Deliv. 13 (2), 171\u2013181 (2016).","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"12728_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1039\/D3MA00498H","volume":"5","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Porous nanomaterials for biosensing and related biological application in in vitro\/vivo usability. Mater. Adv. 5 (2), 453\u2013474 (2024).","journal-title":"Mater. Adv."},{"issue":"8","key":"12728_CR57","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/alr.21963","volume":"7","author":"GF Adriaensen","year":"2017","unstructured":"Adriaensen, G. F., Lim, K. H., & Fokkens, W. J. (2017, August). Safety and efficacy of a bioabsorbable fluticasone propionate\u2013eluting sinus dressing in postoperative management of endoscopic sinus surgery: a randomized clinical trial. In International forum of allergy & rhinology  7 (8), 813-820.","journal-title":"In International forum of allergy & rhinology"},{"issue":"1","key":"12728_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1747-4477.2008.00126.x","volume":"35","author":"N Ballal","year":"2009","unstructured":"Ballal, N. et al. Susceptibility of Candida albicans and Enterococcus faecalis to chitosan, chlorhexidine gluconate and their combination in vitro. Australian Endodontic J. 35 (1), 29\u201333 (2009).","journal-title":"Australian Endodontic J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12728-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:42:04Z","timestamp":1757382124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12728-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12728-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental protocols were approved by the RLCP Ethical Review Board of Riphah International University Faisalabad, PO. Box 38000, Pakistan with IRB No (RLCP\/101\/2024), and they were carried out in accordance with the Declaration of Helsinki World Medical Association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"29520"}}